Forward-looking statements may include, among others, statements concerning future financial or operating performance, including our ability to (i) further evolve our pharmacy benefit management model, (ii) increase access to medicines, (iii) drive greater simplicity with strategies to further reduce cost and improve health and pharmacy care, (iv) drive transparency and predictability to consumers and clients, (v) enhance disclosure practices
The incidence of BPI has been increasing
Ethics declarations Conflict of interest F.C.S declares grants from NIH/NIDDK (P30 DK040561, U24 DK132733, and UE5 DK137285) and consulting fees from Eli Lilly, Novo Nordisk, Amgen, Boehringer Ingelheim, AstraZeneca, AbbVie, Currax, Pfizer, Doximity, MelliCell, Vida Health, Empros Pharma, Apnimed, Clearmind Medicine, and Ilant Health, all outside of the current work
Medicare doesn't usually cover semaglutide drugs for weight loss
The medical route sells fewer fantasies, more friction, and better odds of not making a preventable mistake
